Attachment IV - Page 12 
and what the protocol is designed to accomplish with regard to it 
(points I-A-1,2,3 [p.2942]). And questions about eventual access 
policies are logical extensions of the equity issues involved 
initially in selecting patients for the proposed trials (point I-C-5 
[p.2944]). In some ways, these are the issues that scientists and 
policy-makers thinking about this research need the most help in 
considering. The Working Group could be very useful in that by 
discouraging the attitude that they are questions external to and 
imposed on sound scientific research planning. 
I hope these comments are helpful in the Working Group's 
deliberations. If questions arise about them, please feel free to 
contact me. 
Eric T. Juengi 
Adjunct Lecturer ii. 
Sincerely, 
cc. L. Walters 
[ 39 ] 
